Reason for request
Extension of indication
Clinical Benefit
| Substantial |
Substantial in type 1 diabetes in children aged 2 to 5 years. |
Clinical Added Value
| no clinical added value |
LANTUS provides no improvement in actual benefit (IAB V, non-existent) in the management of children aged 2 to 5 years with type 1 diabetes. |
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
51kcs1XcZCCbVgnS
Listen
